Gut microbiota and gastrointestinal health: current concepts and future directions

被引:200
作者
Aziz, Q. [1 ]
Dore, J. [2 ]
Emmanuel, A. [3 ]
Guarner, F. [4 ]
Quigley, E. M. M. [5 ]
机构
[1] Queen Mary Univ London, Barts & London Sch Med & Dent, Wingate Inst Neurogastroenterol, Ctr Digest Dis,Blizard Inst Cell & Mol Sci, London E1 2AJ, England
[2] INRA, Unite Ecol & Physiol Syst Digestif, Jouy En Josas, France
[3] UCL, GI Physiol Unit, London, England
[4] Univ Hosp Vall dHebron, Digest Syst Res Unit, Barcelona, Spain
[5] Natl Univ Ireland Univ Coll Cork, Alimentary Pharmabiot Ctr, Dept Med, Cork, Ireland
基金
爱尔兰科学基金会;
关键词
brain gut axis; functional; gut; microbiota; IRRITABLE-BOWEL-SYNDROME; 16S RIBOSOMAL-RNA; INTESTINAL MICROBIOTA; CROHNS-DISEASE; FECAL MICROBIOTA; ENTERIC MICROBIOTA; TEMPORAL STABILITY; BRAIN AXIS; PROBIOTICS; LACTOBACILLUS;
D O I
10.1111/nmo.12046
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background The microbial community of the human gut - the enteric microbiota - plays a critical role in functions that sustain health and is a positive asset in host defenses. In recent years, our understanding of this so-called human 'super organism' has advanced, following characterization of fecal metagenomes which identified three core bacterial enterotypes, and based on basic and clinical research into the impact and consequences of microbiota biodiversity and change on gastrointestinal disorders and diseases. Purpose This article considers current knowledge and future perspectives on the make-up and function of human gut microbiota, with a particular focus on altered microbiota and gastrointestinal disorders, nutritional influences on the gut microbiota, and the consequences for gastrointestinal health, as well as improved understanding of gut-microbiota-brain communication.
引用
收藏
页码:4 / 15
页数:12
相关论文
共 95 条
[51]   Diet, gut microbiota and immune responses [J].
Maslowski, Kendle M. ;
Mackay, Charles R. .
NATURE IMMUNOLOGY, 2011, 12 (01) :5-9
[52]   Anti biotic-associated diarrhea: epidemiology, trends and treatment [J].
McFarland, Lynne V. .
FUTURE MICROBIOLOGY, 2008, 3 (05) :563-578
[53]   Meta-analysis of probiotics for the treatment of irritable bowel syndrome [J].
McFarland, Lynne V. ;
Dublin, Sascha .
WORLD JOURNAL OF GASTROENTEROLOGY, 2008, 14 (17) :2650-2661
[54]   Targeting the microbiota-gut-brain axis to modulate behavior: Which bacterial strain will translate best to humans? [J].
McLean, Peter G. ;
Bergonzelli, Gabriella E. ;
Collins, Stephen M. ;
Bercik, Premysl .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2012, 109 (04) :E174-E174
[55]   Drug therapy: Irritable bowel syndrome [J].
Mertz, HR .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (22) :2136-2146
[56]   Beneficial psychological effects of a probiotic formulation (Lactobacillus helveticus R0052 and Bifidobacterium longum R0175) in healthy human volunteers [J].
Messaoudi, Michael ;
Violle, Nicolas ;
Bisson, Jean-Francois ;
Desor, Didier ;
Javelot, Herve ;
Rougeot, Catherine .
GUT MICROBES, 2011, 2 (04) :256-261
[57]   The efficacy of probiotics in the treatment of irritable bowel syndrome: a systematic review [J].
Moayyedi, P. ;
Ford, A. C. ;
Talley, N. J. ;
Cremonini, F. ;
Foxx-Orenstein, A. E. ;
Brandt, L. J. ;
Quigley, E. M. M. .
GUT, 2010, 59 (03) :325-332
[58]   Imbalance in the composition of the duodenal microbiota of children with coeliac disease [J].
Nadal, Inrnaculada ;
Donant, Esther ;
Ribes-Koninckx, Carmen ;
Calabuig, Miguel ;
Sanz, Yolanda .
JOURNAL OF MEDICAL MICROBIOLOGY, 2007, 56 (12) :1669-1674
[59]   Reduced anxiety-like behavior and central neurochemical change in germ-free mice [J].
Neufeld, K. M. ;
Kang, N. ;
Bienenstock, J. ;
Foster, J. A. .
NEUROGASTROENTEROLOGY AND MOTILITY, 2011, 23 (03) :255-e119
[60]   Host-Gut Microbiota Metabolic Interactions [J].
Nicholson, Jeremy K. ;
Holmes, Elaine ;
Kinross, James ;
Burcelin, Remy ;
Gibson, Glenn ;
Jia, Wei ;
Pettersson, Sven .
SCIENCE, 2012, 336 (6086) :1262-1267